Evidence map›Paper›PMID 21775977›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2011

Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction.

Viswanath V Venugopalan, Kevin F Casey, Caitlin O'Hara, Jennifer O'Loughlin, Chawki Benkelfat, Lesley K Fellows, Marco Leyton

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Trial
  2. A novel stress-based intervention reduces cigarette use in non-treatment seeking smokers.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  3. Trial
  4. Dopamine Depletion Reduces Food-Related Reward Activity Independent of BMI.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Trial
  5. Trial
  6. Trial
  7. Amping up effort: effects of d-amphetamine on human effort-based decision-making.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Trial
  8. Lost in translation: why don't dopamine D2 antagonists cure addictions?Journal of psychiatry & neuroscience : JPN · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Dose-response effects of d-amphetamine on effort-based decision-making and reinforcement learning.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Viswanath V VenugopalanDepartment of Neurology, McGill University, Montreal, QC, Canada.
Kevin F Casey
Caitlin O'Hara
Jennifer O'Loughlin
Chawki Benkelfat
Lesley K Fellows
Marco Leyton

Funding

Orbitofrontal and striatal mechanisms in stress and addictionR21DA022630 · NIDA · MCGILL UNIVERSITY · PI FELLOWS, LESLEY K · 2006 to 2009
$447k
CIHR 79919CIHR DA022630CIHR RAN-79911NIDA NIH HHS R21 DA022630NINDS NIH HHS NS-82249
6 · The paper itself

Abstract

The neurobiology of tobacco use is poorly understood, possibly in part because the relevant mechanisms might differ depending on past nicotine exposure and degree of addiction. In the present study we investigated whether these factors might affect the role of dopamine (DA). Using the acute phenylalanine/tyrosine depletion method (APTD), DA synthesis was transiently decreased in three groups of abstinent smokers (n=47): (1) early low-frequency smokers, who had smoked a maximum of five cigarettes per day for less than one year, (2) stable low-frequency smokers smoking at the same level as early low-frequency smokers for at least 3 years, and (3) stable high-frequency smokers, who smoked a minimum of 10 or more cigarettes per day for at least 5 years. Motivation to obtain tobacco was measured using a progressive ratio breakpoint schedule for nicotine-containing and de-nicotinized cigarettes. Compared with a nutritionally balanced control mixture, APTD decreased the self-administration of nicotine-containing cigarettes, and this occurred in all three groups of smokers. The results suggest that DA influenced the willingness to sustain effort for nicotine reward, and this was seen in participants at all three levels of cigarette addiction. In the transition from sporadic to addicted use, the role of DA in the motivation to seek drug may change less than previously proposed.

Indexed as

AdolescentAdultBehavior, AddictiveFemaleHumansMaleMotivationPhenylalanineSmokingSmoking CessationTime FactorsTyrosineYoung AdultPhenylalanineTyrosine

Identifiers

PMID21775977
PMCPMC3194074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.